Morning Movers 12/08: (DMAN) (AFFY) (PSUN) (GIII) Higher; (ALXA) (THQI) (AMR) (IVC) Lower
Tweet
Share
E-mail
Get Alerts DMAN Hot Sheet
Join SI Premium – FREE
DemandTec (Nasdaq: DMAN) 55.3% HIGHER; IBM (NYSE: IBM) to acquire DemandTec for $13.20/share. Click here to see the full report.
Affymax (Nasdaq: AFFY) 37.1% HIGHER; wins FDA panel backing of anemia drug, peginesatide. The vote was 15-1-1. Stock currently halted.
Alexza Pharmaceuticals (Nasdaq: ALXA) 36.4% LOWER; shares selling off ahead of an FDA panel meeting next week on the company's inhaled antipsychotic drug. Word today suggests there may be a risk for respiratory failure. An analyst at RBC Capital said Alexza has an "uphill battle" next week.
THQ Inc. (Nasdaq: THQI) 28.8% LOWER; sees Q3 sales 25% below prior view of $510-$550M. Click here to see the full report.
Pacific Sunwear Of California (NASDAQ: PSUN) 25.9% HIGHER; reported Q3 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $242 million versus the consensus estimate of $232.77 million. Total Company same-store sales decreased 3% during the period. Pacific Sunwear Of California sees Q4 2011 EPS of ($0.18)-($0.27), versus the consensus of ($0.26). Also announced it will undergo a real estate restructuring, closing 175-200 underperforming stores and a new $100 million revolving credit facility with Wells Fargo. Click here to see the full report.
AMR Corp. (NYSE: AMR) 24.6% LOWER; extreme volatility continues in this name this week. The stock is below the $1 level today. Most traders would view today's move lower as prudent by investors in the stock: shares of AMR surged more than 250 percent since news of the Chapter 11 filing.
Invacare Corporation (NYSE: IVC) 20.9% LOWER; reports the U.S. Food and Drug Administration (FDA) has requested that the Company negotiate and agree to a consent decree of injunction relating to previously disclosed inspectional observations at the Company’s corporate facility and its wheelchair manufacturing facility in Elyria, Ohio.
G-III Apparel Group Ltd (NASDAQ: GIII) 16.7% HIGHER; reported Q3 EPS of $2.16, $0.02 better than the analyst estimate of $2.14. Revenue for the quarter came in at $510 million versus the consensus estimate of $497.49 million. Slashes its FY12 EPS guidance from $3.05-$3.15 to $2.50-$2.60, which compares to the current Street estimate of $2.80. Affirms sales guidance of about $1.25 billion. Reports license for development of Calvin Klein Women's Performance Retail Stores.
Central European Distribution Corp. (Nasdaq: CEDC) 15.1% HIGHER; In a 13D filing on CEDC after the close Wednesday afternoon, Russian Standard Corp. disclosed a letter sent to CEDC on December 6th which proposed a deal between the two which could "result in substantial benefits to the Issuer including increased cash flow, increased revenue, higher efficiency and cost savings." Click here to see the full report.
Blyth, Inc. (NYSE: BTH) 14.5% LOWER; Normalized Earnings Per Share for 2011 is anticipated to be in the range of $3.30 to $3.50. The 2011 guidance on a reported basis is $1.65 to $1.85 and compares to prior reported earnings per share guidance of $2.23 – $2.43. Click here to see the full report.
E Commerce China Dangdang (NYSE: DANG) 12.3% HIGHER; appears to have bounced off the 200-day SMA just minutes after the opening. Volume is extremely heavy this morning.
McClatchy (NYSE: MNI) 12.2% LOWER; profit taking today following a nearly 62 percent surge yesterday amid strong FY12 guidance.
Healthways (Nasdaq: HWAY) 11.6% HIGHER; upgraded from Hold to Buy at Stifel Nicolaus this morning.
Frontline (NYSE: FRO) 10.4% LOWER; continuing move lower following a 34 percent jump in Monday and Tuesday.
Tesla (Nasdaq: TSLA) 9.4% LOWER; downgraded by two notches from Overweight to Underweight at Morgan Stanley this morning.
Affymax (Nasdaq: AFFY) 37.1% HIGHER; wins FDA panel backing of anemia drug, peginesatide. The vote was 15-1-1. Stock currently halted.
Alexza Pharmaceuticals (Nasdaq: ALXA) 36.4% LOWER; shares selling off ahead of an FDA panel meeting next week on the company's inhaled antipsychotic drug. Word today suggests there may be a risk for respiratory failure. An analyst at RBC Capital said Alexza has an "uphill battle" next week.
THQ Inc. (Nasdaq: THQI) 28.8% LOWER; sees Q3 sales 25% below prior view of $510-$550M. Click here to see the full report.
Pacific Sunwear Of California (NASDAQ: PSUN) 25.9% HIGHER; reported Q3 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $242 million versus the consensus estimate of $232.77 million. Total Company same-store sales decreased 3% during the period. Pacific Sunwear Of California sees Q4 2011 EPS of ($0.18)-($0.27), versus the consensus of ($0.26). Also announced it will undergo a real estate restructuring, closing 175-200 underperforming stores and a new $100 million revolving credit facility with Wells Fargo. Click here to see the full report.
AMR Corp. (NYSE: AMR) 24.6% LOWER; extreme volatility continues in this name this week. The stock is below the $1 level today. Most traders would view today's move lower as prudent by investors in the stock: shares of AMR surged more than 250 percent since news of the Chapter 11 filing.
Invacare Corporation (NYSE: IVC) 20.9% LOWER; reports the U.S. Food and Drug Administration (FDA) has requested that the Company negotiate and agree to a consent decree of injunction relating to previously disclosed inspectional observations at the Company’s corporate facility and its wheelchair manufacturing facility in Elyria, Ohio.
G-III Apparel Group Ltd (NASDAQ: GIII) 16.7% HIGHER; reported Q3 EPS of $2.16, $0.02 better than the analyst estimate of $2.14. Revenue for the quarter came in at $510 million versus the consensus estimate of $497.49 million. Slashes its FY12 EPS guidance from $3.05-$3.15 to $2.50-$2.60, which compares to the current Street estimate of $2.80. Affirms sales guidance of about $1.25 billion. Reports license for development of Calvin Klein Women's Performance Retail Stores.
Central European Distribution Corp. (Nasdaq: CEDC) 15.1% HIGHER; In a 13D filing on CEDC after the close Wednesday afternoon, Russian Standard Corp. disclosed a letter sent to CEDC on December 6th which proposed a deal between the two which could "result in substantial benefits to the Issuer including increased cash flow, increased revenue, higher efficiency and cost savings." Click here to see the full report.
Blyth, Inc. (NYSE: BTH) 14.5% LOWER; Normalized Earnings Per Share for 2011 is anticipated to be in the range of $3.30 to $3.50. The 2011 guidance on a reported basis is $1.65 to $1.85 and compares to prior reported earnings per share guidance of $2.23 – $2.43. Click here to see the full report.
E Commerce China Dangdang (NYSE: DANG) 12.3% HIGHER; appears to have bounced off the 200-day SMA just minutes after the opening. Volume is extremely heavy this morning.
McClatchy (NYSE: MNI) 12.2% LOWER; profit taking today following a nearly 62 percent surge yesterday amid strong FY12 guidance.
Healthways (Nasdaq: HWAY) 11.6% HIGHER; upgraded from Hold to Buy at Stifel Nicolaus this morning.
Frontline (NYSE: FRO) 10.4% LOWER; continuing move lower following a 34 percent jump in Monday and Tuesday.
Tesla (Nasdaq: TSLA) 9.4% LOWER; downgraded by two notches from Overweight to Underweight at Morgan Stanley this morning.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- Meta Platforms, IBM, Caterpillar fall premarket; American Airlines, Chipotle rise
- Anywhere Real Estate Inc. (HOUS) Misses Q1 EPS by 24c, Misses on Revenue
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Stifel, Morgan Stanley, RBC Capital, Morning Movers, Bankruptcy, 13D, Tesla, Earnings, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
